Jensten enters third chapter as Organ eyes upping the acquisitions tempo
Rob Organ, CEO of Jensten Group, looks to up the tempo on acquisitions, as the business also pushes organic growth and its network proposition following Bain Capital deal.
The strategy isn’t fundamentally changing for Jensten with Bain – the global private investment firm – making an investment, Organ noted.
“We’re going to continue to grow organically, and it’s going to be balanced with selective M&A growth as well.
“Like us, Bain can see the opportunity in the UK marketplace, so we are focused in terms of building out our business. We distribute internationally, but in terms of acquisitions, for example, we’re very focused in the UK.”
ScaleIn August last year
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk or view our subscription options here: https://subscriptions.insuranceage.co.uk/subscribe
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@insuranceage.co.uk